Upon ex vivostimulation with IL-36α and IL-36γ, the production of IL-6 and CXCL8 was significantly increased in SLE patients compared with NC, suggesting that IL-36α may act as a pathogenic factor in SLE (105). This evidence concerns the gene IL6 and systemic lupus erythematosus.